^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    DoMore Diagnostic

    i
    Other names: DoMore Diagnostic | Do More Diagnostic
    Evidence

    News

    over2years
    DoMore Diagnostics and Proscia partner to inform personalized treatment decisions for colorectal cancer patients (Proscia Press Release)
    "DoMore Diagnostics...and Proscia...have partnered to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating artificial intelligence (AI)-powered clinical decision support into routine pathology workflows, unlocking new insights that can guide increasingly precise treatment decisions and ensure patients receive optimal care...The partnership paves the way for delivering an integrated solution that combines DoMore Diagnostics’ CE-IVDD marked Histotype Px® Colorectal* digital biomarker with Proscia’s CE-IVDR marked Concentriq® Dx** enterprise pathology platform."
    Licensing / partnership